12R-LOX-IN-2 is a selective 12R-lipoxygenase inhibitor shown to suppress imiquimod-induced keratinocyte hyperproliferation and inflammatory markers like Ki67 and IL-17A in vitro. This compound is a useful research tool for investigating the mechanisms of psoriasis and related dermatological inflammatory conditions.